News
This GLP-1 Is Most Effective for Weight Loss, Study Says
First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide ...
The phase 2 ELAD study of Novo Nordisk's once-daily injectable GLP-1 agonist liraglutide in people with early-stage Alzheimer's has shown that the drug was able to reduce shrinking in the areas ...
However, it is important to note that the study's cross-sectional design means these findings are correlational, not causal; the data do not show that these factors cause interest in GLP-1 use ...
8h
The diabetes and weight loss drugs are “not cost-effective at their current prices, and are largely unavailable to people with lower incomes,” the report said.
Children who are living with severe obesity are more likely to experience a clinically relevant change in BMI when GLP-1 ...
Scientists have been studying other possible health benefits of GLP-1s. Popular obesity and diabetes drugs called GLP-1 ... use disorder," Dr. Maurice O'Farrell, lead author of the study and ...
People booze a lot less when taking GLP-1 drugs like Ozempic, a new study out of Ireland ... statistics show. Monkey Business – stock.adobe.com Harmful alcohol use accounts for about 2.6 ...
Share on Pinterest Research is looking for ways to minimize muscle loss from GLP-1 drugs taken to treat ... said that “this study was helpful to show that some muscle can occur with ...
News Medical on MSN1d
GLP-1 drugs linked to significant BMI reduction in children with severe obesityChildren who are living with severe obesity are more likely to experience a clinically relevant change in BMI when GLP-1 agonist drugs form part of their treatment, new research being presented at ...
People with mental health problems could be prioritised for weight loss jabs, experts have suggested, after a study showed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results